Andra AP fonden raised its stake in Perrigo Company (NYSE:PRGO) by 9.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,700 shares of the company’s stock after acquiring an additional 1,500 shares during the quarter. Andra AP fonden’s holdings in Perrigo were worth $1,414,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently bought and sold shares of PRGO. Allen Investment Management LLC grew its position in shares of Perrigo by 7.1% during the 2nd quarter. Allen Investment Management LLC now owns 7,143 shares of the company’s stock worth $539,000 after buying an additional 473 shares during the period. State Street Corp grew its position in shares of Perrigo by 1.7% during the 2nd quarter. State Street Corp now owns 6,757,086 shares of the company’s stock worth $510,294,000 after buying an additional 112,287 shares during the period. Monetta Financial Services Inc. acquired a new stake in shares of Perrigo during the 2nd quarter worth approximately $755,000. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in shares of Perrigo by 32.5% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 54,530 shares of the company’s stock worth $4,118,000 after buying an additional 13,382 shares during the period. Finally, Legal & General Group Plc grew its position in shares of Perrigo by 2.9% during the 2nd quarter. Legal & General Group Plc now owns 662,068 shares of the company’s stock worth $50,000,000 after buying an additional 18,697 shares during the period. Hedge funds and other institutional investors own 82.47% of the company’s stock.
In other news, EVP Jeffrey Needham sold 3,595 shares of Perrigo stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $89.49, for a total value of $321,716.55. Following the sale, the executive vice president now directly owns 10,118 shares in the company, valued at $905,459.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Thomas Farrington sold 616 shares of Perrigo stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $76.90, for a total transaction of $47,370.40. Following the completion of the sale, the executive vice president now owns 2,724 shares in the company, valued at $209,475.60. The disclosure for this sale can be found here. Insiders sold 6,894 shares of company stock worth $581,320 over the last quarter. 6.90% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2017/11/14/andra-ap-fonden-boosts-holdings-in-perrigo-company-prgo.html.
Perrigo Company (NYSE PRGO) opened at $86.80 on Tuesday. The company has a quick ratio of 1.24, a current ratio of 1.72 and a debt-to-equity ratio of 0.54. Perrigo Company has a one year low of $63.68 and a one year high of $91.95. The firm has a market cap of $12,351.73, a P/E ratio of 17.90, a price-to-earnings-growth ratio of 1.89 and a beta of 0.69.
Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Thursday, November 9th. The company reported $1.39 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.28. Perrigo had a negative net margin of 26.28% and a positive return on equity of 11.60%. The firm had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same quarter in the previous year, the firm posted $1.65 earnings per share. The business’s revenue was down 2.0% on a year-over-year basis. equities research analysts expect that Perrigo Company will post 4.9 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 19th. Stockholders of record on Friday, December 1st will be issued a $0.16 dividend. The ex-dividend date is Thursday, November 30th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.74%. Perrigo’s dividend payout ratio (DPR) is presently -6.99%.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.